Drugs / Digoxine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01443039 | Sep 2011 → Feb 2014 | obesity disorder | Assistance Publique - Hôpitaux de Paris | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01181414 Comparator | Oct 2010 → Nov 2014 | atrial fibrillation, dilated cardiomyopathy, heart failure | Hospital Clinic of Barcelona | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Digoxine | “Digoxine nativelle (solution injectable, ampoule de 0.5mg) : 1 ampoule per os = 0.5 mg” NCT01443039 ↗ |
| Known as | nativelle | “Digoxine nativelle (solution injectable, ampoule de 0.5mg) : 1 ampoule per os = 0.5 mg” NCT01443039 ↗ |
| Route | Oral | “1 ampoule per os = 0.5 mg” NCT01443039 ↗ |